Compounding continues under specific medical-need exemptions: customized doses, formulations with B12 or other additives, and allergen considerations
OGOmed is committed to providing dependable research materials, transparent product information, and a smooth purchasing experience for laboratories and trained personnel seeking trusted peptide products.
BPC-157 is not explicitly named on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500 which is explicitly banned
All hype, no research During CBC's undercover consultation, Seit admitted there was a lack of clinical human studies on BPC-157
I hope I'm correct with that at least
Moreover, the association of specific markers of SnCs and senolytic drugs could be a great combination in the treatment of age-related diseases